Subscribe to receive this FREE daily commentary directly in your email
[widget id=”text-22″]
5 Monster Stocks to Watch For The Week of
September 10
[widget id=”wordads_sidebar_widget-55″]
MICHAEL KRAMER AND THE CLIENTS OF MOTT CAPITAL OWN SHARES OF CELG AND AAPL
[widget id=”text-19″]
The week of September 10 will be a big one for economics, with PPI and CPI on Wednesday and Thursday. Inflation data may be critical this week, as it could seal the deal on an interest rate hike at the September Fed Meeting. But perhaps more important will be the ECB which is set to release its interest rate policy this Thursday.
Yields
When we look at the yield curve, we can see all the yields coming together, also known as flattening of the curve. So what the Fed ultimately does will have a potentially sizeable impact on the bond markets, the yield curve, and currency markets.
Pay attention to the inflation data this week, it will be telling.
Semis
Outside of that, we need to continue to watch the risk-on parts of the markets, which have performed poorly lately. Semis, as measured by the iShares PHLX Semiconductor ETF (SOXX) fell by 2.5 percent last week and nearly 3.5 percent off its highs at the start of September.
Micron
I feel like I’m on repeat mode, but Micron is a big piece of the risk-on trade, so we want to see Micron’s stock regroup this week and move higher. We have identified support around $45.25. Should the stock be able to hold support, then shares have a reasonable shot of running to$49 or $50. If not, then shares fall into the danger zone between $40 to $42.
Biotech
Biotech has also been a risk-on trade that has struggled. The iShares NASDAQ Biotech ETF (IBB) has also fallen by about 3.5 percent since the start of the month. Again, the key to this group may be Celgene. The stock is more than 4 percent below its late August highs. But the stock is up more than 20 percent since the end of May, and this stock is a good barometer of the health of the group.
Celgene
The stock got within spitting distance of technical resistance at $97. For the stock to continue to climb it needs to break through $97, and it has room to run to nearly $111. But should it continue to trend lower, then shares are likely going back to the mid-80’s.
JNJ
Big Pharma has also been a key to the markets recent rise despite, not being a risk-on sector. But JNJ could be a leader in the group as the stock has broken out, rising above resistance at $136.75. Shares could be on their way high to back to $148.
Apple
Apple has a huge week with the new iPhone expected to be on their way, and we find out on September 12. For now, the direction of Apple looks to be lower, to around $215. If $215 doesn’t hold for support, than it goes to $209.
Unlock Deeper Insights with Exclusive Member-Only Video Content on The Market Chronicles YouTube Channel – Just $34.99/Month
11:09
Join this channel to get access to perks:
https://www.youtube.com/channel/UCIIr1ooRsSukPL7rKNr0VHQ/join
Please check out my content on Substack and Seeking Alpha:
https://www.themarketchronicle.com/
https://seekingalpha.com/affiliate_link/Youtube81624
#sp500 #stocks #stockmarket #cpi #fed #qqq #spy #rates
Charts used with the permission of Bloomberg Finance L.P. This report contains independent commentary to be used for informational and educational purposes only. Michael Kramer is a member and investment adviser representative with Mott Capital Management. Mr. Kramer is not affiliated with this company and does not serve on the board of any related company that issued this stock. All opinions and analyses presented by Michael Kramer in this analysis or market report are solely Michael Kramer’s views. Readers should not treat any opinion, viewpoint, or prediction expressed by Michael Kramer as a specific solicitation or recommendation to buy or sell a particular security or follow a particular strategy. Michael Kramer’s analyses are based upon information and independent research that he considers reliable, but neither Michael Kramer nor Mott Capital Management guarantees its completeness or accuracy, and it should not be relied upon as such. Michael Kramer is not under any obligation to update or correct any information presented in his analyses. Mr. Kramer’s statements, guidance, and opinions are subject to change without notice. Past performance is not indicative of future results. Neither Michael Kramer nor Mott Capital Management guarantees any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment commentary presented in this analysis. Strategies or investments discussed may fluctuate in price or value. Investments or strategies mentioned in this analysis may not be suitable for you. This material does not consider your particular investment objectives, financial situation, or needs and is not intended as a recommendation appropriate for you. You must make an independent decision regarding investments or strategies in this analysis. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Before acting on information in this analysis, you should consider whether it is suitable for your circumstances and strongly consider seeking advice from your own financial or investment adviser to determine the suitability of any investment.
0
YouTube Video VVVNT0lJcjFvb1JzU3VrUEw3cktOcjBWSFEuNDQyRkxBcld2N3c
13:59
Join this channel to get access to perks:
https://www.youtube.com/channel/UCIIr1ooRsSukPL7rKNr0VHQ/join
Please check out my content on Substack and Seeking Alpha:
https://www.themarketchronicle.com/
https://seekingalpha.com/affiliate_link/Youtube81624
#sp500 #stocks #stockmarket #cpi #fed #qqq #spy #rates
Charts used with the permission of Bloomberg Finance L.P. This report contains independent commentary to be used for informational and educational purposes only. Michael Kramer is a member and investment adviser representative with Mott Capital Management. Mr. Kramer is not affiliated with this company and does not serve on the board of any related company that issued this stock. All opinions and analyses presented by Michael Kramer in this analysis or market report are solely Michael Kramer’s views. Readers should not treat any opinion, viewpoint, or prediction expressed by Michael Kramer as a specific solicitation or recommendation to buy or sell a particular security or follow a particular strategy. Michael Kramer’s analyses are based upon information and independent research that he considers reliable, but neither Michael Kramer nor Mott Capital Management guarantees its completeness or accuracy, and it should not be relied upon as such. Michael Kramer is not under any obligation to update or correct any information presented in his analyses. Mr. Kramer’s statements, guidance, and opinions are subject to change without notice. Past performance is not indicative of future results. Neither Michael Kramer nor Mott Capital Management guarantees any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment commentary presented in this analysis. Strategies or investments discussed may fluctuate in price or value. Investments or strategies mentioned in this analysis may not be suitable for you. This material does not consider your particular investment objectives, financial situation, or needs and is not intended as a recommendation appropriate for you. You must make an independent decision regarding investments or strategies in this analysis. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Before acting on information in this analysis, you should consider whether it is suitable for your circumstances and strongly consider seeking advice from your own financial or investment adviser to determine the suitability of any investment.
2
YouTube Video VVVNT0lJcjFvb1JzU3VrUEw3cktOcjBWSFEuaGRQOC10a295Vmc
11:17
Join this channel to get access to perks:
https://www.youtube.com/channel/UCIIr1ooRsSukPL7rKNr0VHQ/join
Please check out my content on Substack and Seeking Alpha:
https://www.themarketchronicle.com/
https://seekingalpha.com/affiliate_link/Youtube81624
#sp500 #stocks #stockmarket #cpi #fed #qqq #spy #rates
Charts used with the permission of Bloomberg Finance L.P. This report contains independent commentary to be used for informational and educational purposes only. Michael Kramer is a member and investment adviser representative with Mott Capital Management. Mr. Kramer is not affiliated with this company and does not serve on the board of any related company that issued this stock. All opinions and analyses presented by Michael Kramer in this analysis or market report are solely Michael Kramer’s views. Readers should not treat any opinion, viewpoint, or prediction expressed by Michael Kramer as a specific solicitation or recommendation to buy or sell a particular security or follow a particular strategy. Michael Kramer’s analyses are based upon information and independent research that he considers reliable, but neither Michael Kramer nor Mott Capital Management guarantees its completeness or accuracy, and it should not be relied upon as such. Michael Kramer is not under any obligation to update or correct any information presented in his analyses. Mr. Kramer’s statements, guidance, and opinions are subject to change without notice. Past performance is not indicative of future results. Neither Michael Kramer nor Mott Capital Management guarantees any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment commentary presented in this analysis. Strategies or investments discussed may fluctuate in price or value. Investments or strategies mentioned in this analysis may not be suitable for you. This material does not consider your particular investment objectives, financial situation, or needs and is not intended as a recommendation appropriate for you. You must make an independent decision regarding investments or strategies in this analysis. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Before acting on information in this analysis, you should consider whether it is suitable for your circumstances and strongly consider seeking advice from your own financial or investment adviser to determine the suitability of any investment.
2
YouTube Video VVVNT0lJcjFvb1JzU3VrUEw3cktOcjBWSFEuVVdHeldSQWpkOTg
JPMorgan
The banks are going to be another group to watch, especially if that yield curve keeps flattening. JPMorgan is the leader there, and for now, shares seem to be trending lower towards $112.
Good Luck this week!
-Mike
Subscriber Video’s
Michael Kramer is the Founder of Mott Capital and the creator of Reading the Markets.
2 Stocks To Consider If You Like Square
Big Biotech Breakout, Plus iPhone Super Cycle Maybe This Year!
Biotech And Semis Breaking Out?
FAANG’s Not Out Of The Woods But Getting Better
Verizon Nears Multiyear Break Out As 5G Data Speeds Near
Amazon May Plunge 10%
The Dollar May Soon Wreak Havoc On Oil And Gold
Inflation Runs Rampant Only In Fantasyland, And That Is Good For Stocks
Tesla May Be Going Higher Regardless Of The Bid
Why The S&P 500 May Rise To 3,500
Why Apple May Rise By 50%
Facebook’s Growth Issue
Netflix Is Not Broken, Plus S&P May Rise To 3,000 Sooner Than You Think
Mott Capital Management, LLC is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Past performance is not indicative of future.
Subscribe to receive this FREE daily commentary directly in your email
Charts used with the permission of Bloomberg Finance L.P. This report contains independent commentary to be used for informational and educational purposes only. Michael Kramer is a member and investment adviser representative with Mott Capital Management. Mr. Kramer is not affiliated with this company and does not serve on the board of any related company that issued this stock. All opinions and analyses presented by Michael Kramer in this analysis or market report are solely Michael Kramer’s views. Readers should not treat any opinion, viewpoint, or prediction expressed by Michael Kramer as a specific solicitation or recommendation to buy or sell a particular security or follow a particular strategy. Michael Kramer’s analyses are based upon information and independent research that he considers reliable, but neither Michael Kramer nor Mott Capital Management guarantees its completeness or accuracy, and it should not be relied upon as such. Michael Kramer is not under any obligation to update or correct any information presented in his analyses. Mr. Kramer’s statements, guidance, and opinions are subject to change without notice. Past performance is not indicative of future results. Neither Michael Kramer nor Mott Capital Management guarantees any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment commentary presented in this analysis. Strategies or investments discussed may fluctuate in price or value. Investments or strategies mentioned in this analysis may not be suitable for you. This material does not consider your particular investment objectives, financial situation, or needs and is not intended as a recommendation appropriate for you. You must make an independent decision regarding investments or strategies in this analysis. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Before acting on information in this analysis, you should consider whether it is suitable for your circumstances and strongly consider seeking advice from your own financial or investment adviser to determine the suitability of any investment.
Liquidity Strains Persist Creating Dangerous Market Back Drop
Mott Capital's Market Chronicles 8 hours ago